| Schedule of Results by Segment |
| | | | | | | | | | | | | | | | | | | Quarter ended | | Nine months ended | | May 30,
2024 | June 1,
2023 | | May 30,
2024 | June 1,
2023 | | | | | | | | Revenue | | | | | | | CNBU | $ | 2,573 | | $ | 1,389 | | | $ | 6,495 | | $ | 4,510 | | | MBU | 1,588 | | 819 | | | 4,479 | | 2,419 | | | EBU | 1,294 | | 912 | | | 3,442 | | 2,777 | | | SBU | 1,353 | | 627 | | | 2,911 | | 1,814 | | | All Other | 3 | | 5 | | | 34 | | 10 | | | $ | 6,811 | | $ | 3,752 | | | $ | 17,361 | | $ | 11,530 | | | | | | | | | Operating income (loss) | | | | | | | CNBU | $ | 442 | | $ | (337) | | | $ | 73 | | $ | (182) | | | MBU | 301 | | (478) | | | (395) | | (1,017) | | | EBU | 124 | | 65 | | | 133 | | 347 | | | SBU | 76 | | (601) | | | (631) | | (1,215) | | | All Other | (2) | | 2 | | | 23 | | 6 | | | 941 | | (1,349) | | | (797) | | (2,061) | | | | | | | | | Unallocated | | | | | | | Stock-based compensation | (217) | | (151) | | | (608) | | (413) | | | Restructure and asset impairments | — | | (68) | | | — | | (167) | | Provision to write-down inventories to net realizable value | — | | (401) | | | — | | (1,831) | | | Lower costs from sale of inventory written down in prior periods | — | | 281 | | | 987 | | 281 | | Patent cross-license agreement gain | — | | — | | | 200 | | — | | Litigation settlement | — | | (68) | | | — | | (68) | | | Other | (5) | | (5) | | | — | | (14) | | | (222) | | (412) | | | 579 | | (2,212) | | | | | | | | Operating income (loss) | $ | 719 | | $ | (1,761) | | | $ | (218) | | $ | (4,273) | |
|